Risk Reduction from HPV Vaccination Goes Beyond Cervical Cancer

New research will be presented at 2024 ASCO Annual Meeting

Results from a new study suggest that the human papillomavirus (HPV) vaccine is effective in preventing the development of several types of cancers caused by HPV, most particularly head and neck cancer in males. The research will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 31-June 4 in Chicago, Illinois.

Login Or Register To Read Full Story